Arisa Akashi Sin
Lawyers
Filters
European Biotech Acquisition $220 million combination with Oculis
We advised European Biotech Acquisition on its de-SPAC transaction
Sun Country Airlines $103.69 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Precigen $75 million follow-on offering
We advised Precigen on the SEC-registered offering
Cactus $172.5 million follow-on offering
We advised Cactus on the stock offering
Tellurian $500 million at-the-market offering
The shares are listed on the NYSE
ADT $1.2 billion cash tender offer for stock
The company’s shares are traded on the NYSE
European Biotech Acquisition $200 million combination with Oculis
We are advising European Biotech Acquisition Corp. on its deSPAC transaction
Solid Biosciences $75 million common stock PIPE offering
The financing is taking place concurrently with the company’s acquisition of AavantiBio
Tellurian $500 million registered direct offering
The convertible senior secured notes are due 2025
Virgin Acquisition Corp. II $1.5 billion combination with Grove Collaborative
We are advising Virgin Acquisition Corp. II on the transaction